Membrane signaling induced by high doses of ionizing radiation in the endothelial compartment. Relevance in radiation toxicity

International Journal of Molecular Sciences

Volumn 14, Issue 11, 2013, Pages 22678-22696

  Corre, Isabelle ^a   Guillonneau, Maëva ^a   Paris, François ^a  

^a UNIVERSITÉ DE NANTES   (France)

Author keywords

Acid sphingomyelinase; Ceramide; Endothelium; Plasma membrane; Radiation toxicity; Radiotherapy

Indexed keywords

CASPASE 7; CD40 ANTIGEN; CERAMIDE; DYSFERLIN; FAS ANTIGEN; GLUTATHIONE; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; SNARE PROTEIN; SPHINGOMYELIN PHOSPHODIESTERASE; SPHINGOSINE 1 PHOSPHATE; SYNTAXIN 4; TUMOR NECROSIS FACTOR ALPHA;

CANCER CELL; CELL MEMBRANE; CELL MIGRATION; ENDOTHELIAL DYSFUNCTION; ENZYME ACTIVATION; GENE; HUMAN; IONIZING RADIATION; LYSOSOME; MICROVASCULAR ENDOTHELIAL CELL; MOLECULAR DYNAMICS; NONHUMAN; PH; PROTEIN TRANSPORT; RADIATION DOSE; RADIATION INJURY; RADIATION TOXICITY; RADIOBIOLOGY; REVIEW; SIGNAL TRANSDUCTION; SMPD1 GENE;

APOPTOSIS; ENDOTHELIAL CELLS; HUMANS; MEMBRANES; NEOPLASMS; RADIATION DOSAGE; RADIATION TOLERANCE; RADIATION, IONIZING; SIGNAL TRANSDUCTION;

EID: 84887907614     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms141122678     Document Type: Review

References (103)

1. Stone, H. B.; Coleman, C. N.; Anscher, M. S.; McBride, W. H. Effects of radiation on normal tissue: Consequences and mechanisms. Lancet Oncol. 2003, 4, 529-536.
2. Bhide, S. A.; Nutting, C. M. Recent advances in radiotherapy. BMC Med. 2010, 8, 25.
3. Almaghrabi, M. Y.; Supiot, S.; Paris, F.; Mahe, M. A.; Rio, E. Stereotactic body radiation therapy for abdominal oligometastases: A biological and clinical review. Radiat. Oncol. 2012, 7, doi: 10. 1186/1748-717X-7-126.
4. Lo, S. S.; Fakiris, A. J.; Chang, E. L.; Mayr, N. A.; Wang, J. Z.; Papiez, L.; Teh, B. S.; McGarry, R. C.; Cardenes, H. R.; Timmerman, R. D. Stereotactic body radiation therapy: A novel treatment modality. Nat. Rev. Clin. Oncol. 2010, 7, 44-54.
5. Milano, M. T.; Constine, L. S.; Okunieff, P. Normal tissue toxicity after small field hypofractionated stereotactic body radiation. Radiat. Oncol. 2008, 3, 36.
6. Brown, J. M.; Koong, A. C. High-dose single-fraction radiotherapy: Exploiting a new biology? Int. J. Radiat. Oncol. Biol. Phys. 2008, 71, 324-325.
7. Pena, L. A.; Fuks, Z.; Kolesnick, R. N. Radiation-induced apoptosis of endothelial cells in the murine central nervous system: Protection by fibroblast growth factor and sphingomyelinase deficiency. Cancer Res. 2000, 60, 321-327.
8. Paris, F.; Fuks, Z.; Kang, A.; Capodieci, P.; Juan, G.; Ehleiter, D.; Haimovitz-Friedman, A.; Cordon-Cardo, C.; Kolesnick, R. Endothelial apoptosis as the primary lesion initiating intestinal radiation damage in mice. Science 2001, 293, 293-297.
9. Rodemann, H. P.; Blaese, M. A. Responses of normal cells to ionizing radiation. Semin. Radiat. Oncol. 2007, 17, 81-88.
10. Gaugler, M. H. A unifying system: Does the vascular endothelium have a role to play in multi-organ failure following radiation exposure? BJR Suppl. 2005, 27, 100-105.
11. Milliat, F.; Francois, A.; Tamarat, R.; Benderitter, M. Role of endothelium in radiation-induced normal tissue damages. Ann. Cardiol. Angeiol. 2008, 57, 139-148.
12. Oh, C. W.; Bump, E. A.; Kim, J. S.; Janigro, D.; Mayberg, M. R. Induction of a senescence-like phenotype in bovine aortic endothelial cells by ionizing radiation. Radiat. Res. 2001, 156, 232-240.
13. Supiot, S.; Paris, F. Radiobiology dedicated to endothelium. Cancer Radiother. 2012, 16, 11-15.
14. Garcia-Barros, M.; Paris, F.; Cordon-Cardo, C.; Lyden, D.; Rafii, S.; Haimovitz-Friedman, A.; Fuks, Z.; Kolesnick, R. Tumor response to radiotherapy regulated by endothelial cell apoptosis. Science 2003, 300, 1155-1159.
15. Fuks, Z.; Kolesnick, R. Engaging the vascular component of the tumor response. Cancer Cell 2005, 8, 89-91.
16. Haimovitz-Friedman, A.; Kan, C. C.; Ehleiter, D.; Persaud, R. S.; McLoughlin, M.; Fuks, Z.; Kolesnick, R. N. Ionizing radiation acts on cellular membranes to generate ceramide and initiate apoptosis. J. Exp. Med. 1994, 180, 525-535.
17. Valerie, K.; Yacoub, A.; Hagan, M. P.; Curiel, D. T.; Fisher, P. B.; Grant, S.; Dent, P. Radiation-induced cell signaling: Inside-out and outside-in. Mol. Cancer Ther. 2007, 6, 789-801.
18. Santana, P.; Pena, L. A.; Haimovitz-Friedman, A.; Martin, S.; Green, D.; McLoughlin, M.; Cordon-Cardo, C.; Schuchman, E. H.; Fuks, Z.; Kolesnick, R. Acid sphingomyelinase-deficient human lymphoblasts and mice are defective in radiation-induced apoptosis. Cell 1996, 86, 189-199.
19. Milhas, D.; Clarke, C. J.; Hannun, Y. A. Sphingomyelin metabolism at the plasma membrane: implications for bioactive sphingolipids. FEBS Lett. 2010, 584, 1887-1894.
20. Schissel, S. L.; Jiang, X.; Tweedie-Hardman, J.; Jeong, T.; Camejo, E. H.; Najib, J.; Rapp, J. H.; Williams, K. J.; Tabas, I. Secretory sphingomyelinase, a product of the acid sphingomyelinase gene, can hydrolyze atherogenic lipoproteins at neutral pH. Implications for atherosclerotic lesion development. J. Biol. Chem. 1998, 273, 2738-2746.
21. Xu, M.; Xia, M.; Li, X. X.; Han, W. Q.; Boini, K. M.; Zhang, F.; Zhang, Y.; Ritter, J. K.; Li, P. L. Requirement of translocated lysosomal V1 H(+)-ATPase for activation of membrane acid sphingomyelinase and raft clustering in coronary endothelial cells. Mol. Biol. Cell 2012, 23, 1546-1557.
22. Charruyer, A.; Grazide, S.; Bezombes, C.; Muller, S.; Laurent, G.; Jaffrezou, J. P. UV-C light induces raft-associated acid sphingomyelinase and JNK activation and translocation independently on a nuclear signal. J. Biol. Chem. 2005, 280, 19196-19204.
23. Dumitru, C. A.; Gulbins, E. TRAIL activates acid sphingomyelinase via a redox mechanism and releases ceramide to trigger apoptosis. Oncogene 2006, 25, 5612-5625.
24. Grassme, H.; Cremesti, A.; Kolesnick, R.; Gulbins, E. Ceramide-mediated clustering is required for CD95-DISC formation. Oncogene 2003, 22, 5457-5470.
25. Truman, J. P.; Garcia-Barros, M.; Kaag, M.; Hambardzumyan, D.; Stancevic, B.; Chan, M.; Fuks, Z.; Kolesnick, R.; Haimovitz-Friedman, A. Endothelial membrane remodeling is obligate for anti-angiogenic radiosensitization during tumor radiosurgery. PLoS One 2010, 5, e12310.
26. Perrotta, C.; Bizzozero, L.; Cazzato, D.; Morlacchi, S.; Assi, E.; Simbari, F.; Zhang, Y.; Gulbins, E.; Bassi, M. T.; Rosa, P.; et al. Syntaxin 4 is required for acid sphingomyelinase activity and apoptotic function. J. Biol. Chem. 2010, 285, 40240-40251.
27. Han, W. Q.; Xia, M.; Xu, M.; Boini, K. M.; Ritter, J. K.; Li, N. J.; Li, P. L. Lysosome fusion to the cell membrane is mediated by the dysferlin C2A domain in coronary arterial endothelial cells. J. Cell Sci. 2012, 125, 1225-1234.
28. Edelmann, B.; Bertsch, U.; Tchikov, V.; Winoto-Morbach, S.; Perrotta, C.; Jakob, M.; Adam-Klages, S.; Kabelitz, D.; Schutze, S. Caspase-8 and caspase-7 sequentially mediate proteolytic activation of acid sphingomyelinase in TNF-R1 receptosomes. EMBO J. 2011, 30, 379-394.
29. Zeidan, Y. H.; Wu, B. X.; Jenkins, R. W.; Obeid, L. M.; Hannun, Y. A. A novel role for protein kinase Cdelta-mediated phosphorylation of acid sphingomyelinase in UV light-induced mitochondrial injury. FASEB J. 2008, 22, 183-193.
30. Qiu, H.; Edmunds, T.; Baker-Malcolm, J.; Karey, K. P.; Estes, S.; Schwarz, C.; Hughes, H.; van Patten, S. M. Activation of human acid sphingomyelinase through modification or deletion of C-terminal cysteine. J. Biol. Chem. 2003, 278, 32744-32752.
31. Lang, P. A.; Schenck, M.; Nicolay, J. P.; Becker, J. U.; Kempe, D. S.; Lupescu, A.; Koka, S.; Eisele, K.; Klarl, B. A.; Rubben, H.; et al. Liver cell death and anemia in Wilson disease involve acid sphingomyelinase and ceramide. Nat. Med. 2007, 13, 164-170.
32. Castillo, S. S.; Levy, M.; Thaikoottathil, J. V.; Goldkorn, T. Reactive nitrogen and oxygen species activate different sphingomyelinases to induce apoptosis in airway epithelial cells. Exp. Cell Res. 2007, 313, 2680-2686.
33. Zhang, A. Y.; Yi, F.; Jin, S.; Xia, M.; Chen, Q. Z.; Gulbins, E.; Li, P. L. Acid sphingomyelinase and its redox amplification in formation of lipid raft redox signaling platforms in endothelial cells. Antioxid. Redox Signal. 2007, 9, 817-828.
34. Azzam, E. I.; Jay-Gerin, J. P.; Pain, D. Ionizing radiation-induced metabolic oxidative stress and prolonged cell injury. Cancer Lett. 2012, 327, 48-60.
35. Paris, F. CRCNA, Nantes, FR. Personal communication, 2013.
36. Kolesnick, R. N.; Goni, F. M.; Alonso, A. Compartmentalization of ceramide signaling: Physical foundations and biological effects. J. Cell Physiol. 2000, 184, 285-300.
37. Holopainen, J. M.; Subramanian, M.; Kinnunen, P. K. Sphingomyelinase induces lipid microdomain formation in a fluid phosphatidylcholine/sphingomyelin membrane. Biochemistry 1998, 37, 17562-17570.
38. Nurminen, T. A.; Holopainen, J. M.; Zhao, H.; Kinnunen, P. K. Observation of topical catalysis by sphingomyelinase coupled to microspheres. J. Am. Chem. Soc. 2002, 124, 12129-12134.
39. Simons, K.; Ikonen, E. Functional rafts in cell membranes. Nature 1997, 387, 569-572.
40. Zhang, Y.; Li, X.; Becker, K. A.; Gulbins, E. Ceramide-enriched membrane domains-Structure and function. Biochim. Biophys. Acta 2009, 1788, 178-183.
41. Stancevic, B.; Kolesnick, R. Ceramide-rich platforms in transmembrane signaling. FEBS Lett. 2010, 584, 1728-1740.
42. Bionda, C.; Hadchity, E.; Alphonse, G.; Chapet, O.; Rousson, R.; Rodriguez-Lafrasse, C.; Ardail, D. Radioresistance of human carcinoma cells is correlated to a defect in raft membrane clustering. Free Radic. Biol. Med. 2007, 43, 681-694.
43. Rotolo, J.; Stancevic, B.; Zhang, J.; Hua, G.; Fuller, J.; Yin, X.; Haimovitz-Friedman, A.; Kim, K.; Qian, M.; Cardo-Vila, M.; et al. Anti-ceramide antibody prevents the radiation gastrointestinal syndrome in mice. J. Clin. Invest. 2012, 122, 1786-1790.
44. Gulbins, E.; Kolesnick, R. Raft ceramide in molecular medicine. Oncogene 2003, 22, 7070-7077.
45. Kolesnick, R.; Fuks, Z. Radiation and ceramide-induced apoptosis. Oncogene 2003, 22, 5897-5906.
46. Bao, J. X.; Jin, S.; Zhang, F.; Wang, Z. C.; Li, N.; Li, P. L. Activation of membrane NADPH oxidase associated with lysosome-targeted acid sphingomyelinase in coronary endothelial cells. Antioxid. Redox Signal. 2010, 12, 703-712.
47. Zhang, A. Y.; Yi, F.; Zhang, G.; Gulbins, E.; Li, P. L. Lipid raft clustering and redox signaling platform formation in coronary arterial endothelial cells. Hypertension 2006, 47, 74-80.
48. Viola, A. The amplification of TCR signaling by dynamic membrane microdomains. Trends Immunol. 2001, 22, 322-327.
49. Li, X.; Han, W. Q.; Boini, K. M.; Xia, M.; Zhang, Y.; Li, P. L. TRAIL death receptor 4 signaling via lysosome fusion and membrane raft clustering in coronary arterial endothelial cells: Evidence from ASM knockout mice. J. Mol. Med. 2013, 91, 25-36.
50. Jin, S.; Zhang, Y.; Yi, F.; Li, P. L. Critical role of lipid raft redox signaling platforms in endostatin-induced coronary endothelial dysfunction. Arterioscler. Thromb. Vasc. Biol. 2008, 28, 485-490.
51. Collins-Underwood, J. R.; Zhao, W.; Sharpe, J. G.; Robbins, M. E. NADPH oxidase mediates radiation-induced oxidative stress in rat brain microvascular endothelial cells. Free Radic. Biol. Med. 2008, 45, 929-938.
52. Contreras, F. X.; Villar, A. V.; Alonso, A.; Kolesnick, R. N.; Goni, F. M. Sphingomyelinase activity causes transbilayer lipid translocation in model and cell membranes. J. Biol. Chem. 2003, 278, 37169-37174.
53. Chalfant, C. E.; Kishikawa, K.; Mumby, M. C.; Kamibayashi, C.; Bielawska, A.; Hannun, Y. A. Long chain ceramides activate protein phosphatase-1 and protein phosphatase-2A. Activation is stereospecific and regulated by phosphatidic acid. J. Biol. Chem. 1999, 274, 20313-20317.
54. Chalfant, C. E.; Szulc, Z.; Roddy, P.; Bielawska, A.; Hannun, Y. A. The structural requirements for ceramide activation of serine-threonine protein phosphatases. J. Lipid Res. 2004, 45, 496-506.
55. Yan, F.; John, S. K.; Polk, D. B. Kinase suppressor of Ras determines survival of intestinal epithelial cells exposed to tumor necrosis factor. Cancer Res. 2001, 61, 8668-8675.
56. Zhang, Y.; Yao, B.; Delikat, S.; Bayoumy, S.; Lin, X. H.; Basu, S.; McGinley, M.; Chan-Hui, P. Y.; Lichenstein, H.; Kolesnick, R. Kinase suppressor of Ras is ceramide-activated protein kinase. Cell 1997, 89, 63-72.
57. Yin, X.; Zafrullah, M.; Lee, H.; Haimovitz-Friedman, A.; Fuks, Z.; Kolesnick, R. A ceramide-binding C1 domain mediates kinase suppressor of ras membrane translocation. Cell Physiol. Biochem. 2009, 24, 219-230.
58. Bourbon, N. A.; Yun, J.; Kester, M. Ceramide directly activates protein kinase C zeta to regulate a stress-activated protein kinase signaling complex. J. Biol. Chem. 2000, 275, 35617-35623.
59. Lozano, J.; Berra, E.; Municio, M. M.; Diaz-Meco, M. T.; Dominguez, I.; Sanz, L.; Moscat, J. Protein kinase C zeta isoform is critical for kappa B-dependent promoter activation by sphingomyelinase. J. Biol. Chem. 1994, 269, 19200-19202.
60. Muller, G.; Ayoub, M.; Storz, P.; Rennecke, J.; Fabbro, D.; Pfizenmaier, K. PKC zeta is a molecular switch in signal transduction of TNF-alpha, bifunctionally regulated by ceramide and arachidonic acid. EMBO J. 1995, 14, 1961-1969.
61. Heinrich, M.; Neumeyer, J.; Jakob, M.; Hallas, C.; Tchikov, V.; Winoto-Morbach, S.; Wickel, M.; Schneider-Brachert, W.; Trauzold, A.; Hethke, A.; et al. Cathepsin D links TNF-induced acid sphingomyelinase to Bid-mediated caspase-9 and-3 activation. Cell Death Differ. 2004, 11, 550-563.
62. Church, L. D.; Hessler, G.; Goodall, J. E.; Rider, D. A.; Workman, C. J.; Vignali, D. A.; Bacon, P. A.; Gulbins, E.; Young, S. P. TNFR1-induced sphingomyelinase activation modulates TCR signaling by impairing store-operated Ca2+ influx. J. Leukoc. Biol. 2005, 78, 266-278.
63. Lepple-Wienhues, A.; Belka, C.; Laun, T.; Jekle, A.; Walter, B.; Wieland, U.; Welz, M.; Heil, L.; Kun, J.; Busch, G.; et al. Stimulation of CD95 (Fas) blocks T lymphocyte calcium channels through sphingomyelinase and sphingolipids. Proc. Natl. Acad. Sci. USA 1999, 96, 13795-13800.
64. Szabo, I.; Gulbins, E.; Apfel, H.; Zhang, X.; Barth, P.; Busch, A. E.; Schlottmann, K.; Pongs, O.; Lang, F. Tyrosine phosphorylation-dependent suppression of a voltage-gated K+ channel in T lymphocytes upon Fas stimulation. J. Biol. Chem. 1996, 271, 20465-20469.
65. Wu, F.; Wilson, J. X. Peroxynitrite-dependent activation of protein phosphatase type 2A mediates microvascular endothelial barrier dysfunction. Cardiovasc. Res. 2009, 81, 38-45.
66. Haendeler, J.; Popp, R.; Goy, C.; Tischler, V.; Zeiher, A. M.; Dimmeler, S. Cathepsin D and H2O2 stimulate degradation of thioredoxin-1: Implication for endothelial cell apoptosis. J. Biol. Chem. 2005, 280, 42945-42951.
67. Oubaha, M.; Gratton, J. P. Phosphorylation of endothelial nitric oxide synthase by atypical PKC zeta contributes to angiopoietin-1-dependent inhibition of VEGF-induced endothelial permeability in vitro. Blood 2009, 114, 3343-3351.
68. Friedman, M.; Ryan, U. S.; Davenport, W. C.; Chaney, E. L.; Strickland, D. L.; Kwock, L. Reversible alterations in cultured pulmonary artery endothelial cell monolayer morphology and albumin permeability induced by ionizing radiation. J. Cell Physiol. 1986, 129, 237-249.
69. Gabrys, D.; Greco, O.; Patel, G.; Prise, K. M.; Tozer, G. M.; Kanthou, C. Radiation effects on the cytoskeleton of endothelial cells and endothelial monolayer permeability. Int. J. Radiat. Oncol. Biol. Phys. 2007, 69, 1553-1562.
70. Rousseau, M.; Gaugler, M. H.; Rodallec, A.; Bonnaud, S.; Paris, F.; Corre, I. RhoA GTPase regulates radiation-induced alterations in endothelial cell adhesion and migration. Biochem. Biophys. Res. Commun. 2011, 414, 750-755.
71. Onoda, J. M.; Kantak, S. S.; Diglio, C. A. Radiation induced endothelial cell retraction in vitro: Correlation with acute pulmonary edema. Pathol. Oncol. Res. 1999, 5, 49-55.
72. Hall, A. Rho family GTPases. Biochem. Soc. Trans. 2012, 40, 1378-1382.
73. Blirando, K.; Hneino, M.; Martelly, I.; Benderitter, M.; Milliat, F.; Francois, A. Mast cells and ionizing radiation induce a synergistic expression of inflammatory genes in endothelial cells by a mechanism involving p38alpha MAP kinase and (p65) NF-kappaB activation. Radiat. Res. 2012, 178, 556-567.
74. Gupta, N.; Nodzenski, E.; Khodarev, N. N.; Yu, J.; Khorasani, L.; Beckett, M. A.; Kufe, D. W.; Weichselbaum, R. R. Angiostatin effects on endothelial cells mediated by ceramide and RhoA. EMBO Rep. 2001, 2, 536-540.
75. Brenner, B.; Koppenhoefer, U.; Weinstock, C.; Linderkamp, O.; Lang, F.; Gulbins, E. Fas-or ceramide-induced apoptosis is mediated by a Rac1-regulated activation of Jun N-terminal kinase/p38 kinases and GADD153. J. Biol. Chem. 1997, 272, 22173-22181.
76. Del Pozo, M. A.; Alderson, N. B.; Kiosses, W. B.; Chiang, H. H.; Anderson, R. G.; Schwartz, M. A. Integrins regulate Rac targeting by internalization of membrane domains. Science 2004, 303, 839-842.
77. Plowman, S. J.; Muncke, C.; Parton, R. G.; Hancock, J. F. H-ras, K-ras, and inner plasma membrane raft proteins operate in nanoclusters with differential dependence on the actin cytoskeleton. Proc. Natl. Acad. Sci. USA 2005, 102, 15500-15505.
78. Bentzen, S. M. Preventing or reducing late side effects of radiation therapy: Radiobiology meets molecular pathology. Nat. Rev. Cancer 2006, 6, 702-713.
79. Adams, M. J.; Hardenbergh, P. H.; Constine, L. S.; Lipshultz, S. E. Radiation-associated cardiovascular disease. Crit. Rev. Oncol. Hematol. 2003, 45, 55-75.
80. Arenz, C. Small molecule inhibitors of acid sphingomyelinase. Cell Physiol. Biochem. 2010, 26, 1-8.
81. Kornhuber, J.; Tripal, P.; Reichel, M.; Muhle, C.; Rhein, C.; Muehlbacher, M.; Groemer, T. W.; Gulbins, E. Functional Inhibitors of Acid Sphingomyelinase (FIASMAs): A novel pharmacological group of drugs with broad clinical applications. Cell Physiol. Biochem. 2010, 26, 9-20.
82. Kornhuber, J.; Muehlbacher, M.; Trapp, S.; Pechmann, S.; Friedl, A.; Reichel, M.; Muhle, C.; Terfloth, L.; Groemer, T. W.; Spitzer, G. M.; et al. Identification of novel functional inhibitors of acid sphingomyelinase. PLoS One 2011, 6, e23852.
83. Nahrlich, L.; Mainz, J. G.; Adams, C.; Engel, C.; Herrmann, G.; Icheva, V.; Lauer, J.; Deppisch, C.; Wirth, A.; Unger, K.; et al. Therapy of CF-patients with amitriptyline and placebo-A randomised, double-blind, placebo-controlled phase IIb multicenter, cohort-study. Cell Physiol. Biochem. 2013, 31, 505-512.
84. Xu, J.; Yan, X.; Gao, R.; Mao, L.; Cotrim, A. P.; Zheng, C.; Zhang, C.; Baum, B. J.; Wang, S. Effect of irradiation on microvascular endothelial cells of parotid glands in the miniature pig. Int. J. Radiat. Oncol. Biol. Phys. 2010, 78, 897-903.
85. Simons, M.; Annex, B. H.; Laham, R. J.; Kleiman, N.; Henry, T.; Dauerman, H.; Udelson, J. E.; Gervino, E. V.; Pike, M.; Whitehouse, M. J.; et al. Pharmacological treatment of coronary artery disease with recombinant fibroblast growth factor-2: Double-blind, randomized, controlled clinical trial. Circulation 2002, 105, 788-793.
86. Ziobro, R.; Henry, B.; Edwards, M. J.; Lentsch, A. B.; Gulbins, E. Ceramide mediates lung fibrosis in cystic fibrosis. Biochem. Biophys. Res. Commun. 2013, 434, 705-709.
87. Cuvillier, O.; Pirianov, G.; Kleuser, B.; Vanek, P. G.; Coso, O. A.; Gutkind, S.; Spiegel, S. Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate. Nature 1996, 381, 800-803.
88. Morita, Y.; Perez, G. I.; Paris, F.; Miranda, S. R.; Ehleiter, D.; Haimovitz-Friedman, A.; Fuks, Z.; Xie, Z.; Reed, J. C.; Schuchman, E. H.; et al. Oocyte apoptosis is suppressed by disruption of the acid sphingomyelinase gene or by sphingosine-1-phosphate therapy. Nat. Med. 2000, 6, 1109-1114.
89. Paris, F.; Perez, G. I.; Fuks, Z.; Haimovitz-Friedman, A.; Nguyen, H.; Bose, M.; Ilagan, A.; Hunt, P. A.; Morgan, W. F.; Tilly, J. L.; et al. Sphingosine 1-phosphate preserves fertility in irradiated female mice without propagating genomic damage in offspring. Nat. Med. 2002, 8, 901-902.
90. Maceyka, M.; Payne, S. G.; Milstien, S.; Spiegel, S. Sphingosine kinase, sphingosine-1-phosphate, and apoptosis. Biochim. Biophys. Acta 2002, 1585, 193-201.
91. Bonnaud, S.; Niaudet, C.; Legoux, F.; Corre, I.; Delpon, G.; Saulquin, X.; Fuks, Z.; Gaugler, M. H.; Kolesnick, R.; Paris, F. Sphingosine-1-phosphate activates the AKT pathway to protect small intestines from radiation-induced endothelial apoptosis. Cancer Res. 2010, 70, 9905-9915.
92. Maceyka, M.; Harikumar, K. B.; Milstien, S.; Spiegel, S. Sphingosine-1-phosphate signaling and its role in disease. Trends Cell Biol. 2012, 22, 50-60.
93. Cho, C. H.; Kammerer, R. A.; Lee, H. J.; Yasunaga, K.; Kim, K. T.; Choi, H. H.; Kim, W.; Kim, S. H.; Park, S. K.; Lee, G. M.; et al. Designed angiopoietin-1 variant, COMP-Ang1, protects against radiation-induced endothelial cell apoptosis. Proc. Natl. Acad. Sci. USA 2004, 101, 5553-5558.
94. Bonnaud, S.; Niaudet, C.; Pottier, G.; Gaugler, M. H.; Millour, J.; Barbet, J.; Sabatier, L.; Paris, F. Sphingosine-1-phosphate protects proliferating endothelial cells from ceramide-induced apoptosis but not from DNA damage-induced mitotic death. Cancer Res. 2007, 67, 1803-1811.
95. Simons, K.; Toomre, D. Lipid rafts and signal transduction. Nat. Rev. Mol. Cell Biol. 2000, 1, 31-39.
96. Matarazzo, S.; Quitadamo, M. C.; Mango, R.; Ciccone, S.; Novelli, G.; Biocca, S. Cholesterol-lowering drugs inhibit lectin-like oxidized low-density lipoprotein-1 receptor function by membrane raft disruption. Mol. Pharmacol. 2012, 82, 246-254.
97. Wei, Y. M.; Li, X.; Xiong, J.; Abais, J. M.; Xia, M.; Boini, K. M.; Zhang, Y.; Li, P. L. Attenuation by statins of membrane raft-redox signaling in coronary arterial endothelium. J. Pharmacol. Exp. Ther. 2013, 345, 170-179.
98. Gaugler, M. H.; Vereycken-Holler, V.; Squiban, C.; Vandamme, M.; Vozenin-Brotons, M. C.; Benderitter, M. Pravastatin limits endothelial activation after irradiation and decreases the resulting inflammatory and thrombotic responses. Radiat. Res. 2005, 163, 479-487.
99. Holler, V.; Buard, V.; Gaugler, M. H.; Guipaud, O.; Baudelin, C.; Sache, A.; Perez Mdel, R.; Squiban, C.; Tamarat, R.; Milliat, F.; et al. Pravastatin limits radiation-induced vascular dysfunction in the skin. J. Invest. Dermatol. 2009, 129, 1280-1291.
100. Jain, M. K.; Ridker, P. M. Anti-inflammatory effects of statins: Clinical evidence and basic mechanisms. Nat. Rev. Drug Discov. 2005, 4, 977-987.
101. Bourgier, C.; Haydont, V.; Milliat, F.; Francois, A.; Holler, V.; Lasser, P.; Bourhis, J.; Mathe, D.; Vozenin-Brotons, M. C. Inhibition of Rho kinase modulates radiation induced fibrogenic phenotype in intestinal smooth muscle cells through alteration of the cytoskeleton and connective tissue growth factor expression. Gut 2005, 54, 336-343.
102. Haydont, V.; Bourgier, C.; Pocard, M.; Lusinchi, A.; Aigueperse, J.; Mathe, D.; Bourhis, J.; Vozenin-Brotons, M. C. Pravastatin Inhibits the Rho/CCN2/extracellular matrix cascade in human fibrosis explants and improves radiation-induced intestinal fibrosis in rats. Clin. Cancer Res. 2007, 13, 5331-5340.
103. Moding, E. J.; Kastan, M. B.; Kirsch, D. G. Strategies for optimizing the response of cancer and normal tissues to radiation. Nat. Rev. Drug Discov. 2013, 12, 526-542.